Contact

Jamie Lacey-Moreira, PressComm PR Principal & Founder

Are you ready to give your communications strategy a new perspective? The PressComm PR team works with life science and health care organizations, delivering a flexible, resource-leveraging communications program.

Please contact Jamie to let us know how we can help your organization:

Jamie Lacey-Moreira, Principal
PressComm PR, LLC
Ph: 410.299.3310
Email: jamielacey@presscommpr.com

News

January 6, 2020

Washington Business Journal: Maryland Biotech Outlines Path for Blood Cancer Drug, Including in China
Rockville biotech GlycoMimetics Inc. has entered into a license agreement worth $189 million or more with a West Coast company. The deal gives cancer therapy [Read More]
December 21, 2019

Technical.ly Baltimore: MTC's Martin Rosendale, UM BioPark's James Hughes and Others Share Their Thoughts on Baltimore's Imagined Future
Imagined futures: Baltimore tech and biz leaders tell us what they envision for the next decade The year is winding down, which offers time to [Read More]
December 19, 2019

MaxCyte Appoints New Executive Vice President, Business Development for CARMA™ Cellular Therapies and Provides Clinical Trial Update
– Shrut Abbato will lead development of new partnerships for the Company’s CARMA platform programs – Phase I trial of lead CARMA candidate MCY-M11 remains [Read More]

PressComm

Contact

Contact

Site Links

Social

About PressComm PR